Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...
Comprehensive metabolite profiling of FFPE tissue to analyze metabolic changes in colorectal cancer.
An innovative evidence-based laboratory medicine (EBLM) test to help doctors in the basic assessment of colorectal cancer. Trend analysis of risk factors for early-onset primary colorectal cancer: A ...
BioEcho Life Sciences, a leading provider of innovative molecular biology solutions, announces the launch of its EchoLUTION FFPE RNA Kit, offering researchers a simplified protocol and superior RNA ...
For decades, formalin-fixing paraffin-embedding has been the preferred method for preserving biological samples for diagnostic research. Formalin is relatively inexpensive and can be used to preserve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results